These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35714333)
1. Clinical trials in desmoid-type fibromatosis in children and adults: A systematic review. van Maren SA; van Noesel MM; Husson O; van der Graaf WTA Pediatr Blood Cancer; 2022 Sep; 69(9):e29831. PubMed ID: 35714333 [TBL] [Abstract][Full Text] [Related]
2. Identification and assessment of health-related quality of life issues in patients with sporadic desmoid-type fibromatosis: a literature review and focus group study. Timbergen MJM; van de Poll-Franse LV; Grünhagen DJ; van der Graaf WT; Sleijfer S; Verhoef C; Husson O Qual Life Res; 2018 Dec; 27(12):3097-3111. PubMed ID: 30014458 [TBL] [Abstract][Full Text] [Related]
3. Novel pathogenic alterations in pediatric and adult desmoid-type fibromatosis - A systematic analysis of 204 cases. Trautmann M; Rehkämper J; Gevensleben H; Becker J; Wardelmann E; Hartmann W; Grünewald I; Huss S Sci Rep; 2020 Feb; 10(1):3368. PubMed ID: 32099073 [TBL] [Abstract][Full Text] [Related]
4. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations. Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042 [TBL] [Abstract][Full Text] [Related]
5. Physical symptom burden in patients with desmoid-type fibromatosis and its impact on health-related quality of life and healthcare use. Schut AW; de Bruin LE; de Rooij BH; Lidington E; Timbergen MJM; van der Graaf WTA; van Houdt WJ; Bonenkamp JJ; Jones RL; Grünhagen DJ; Sleijfer S; Gennatas S; Verhoef C; Husson O Cancer Med; 2023 Jun; 12(12):13661-13674. PubMed ID: 37119048 [TBL] [Abstract][Full Text] [Related]
6. Event-free survival in Desmoid-Type fibromatosis (DTF): A pre-post comparison of upfront surgery versus wait-and-see approach. Ruspi L; Cananzi FCM; Sicoli F; Samà L; Renne SL; Marrari A; Gennaro N; Colombo P; Cozzaglio L; Politi LS; Bertuzzi A; Quagliuolo V Eur J Surg Oncol; 2021 May; 47(5):1196-1200. PubMed ID: 32847695 [TBL] [Abstract][Full Text] [Related]
7. Neuromuscular choristoma-associated desmoid-type fibromatosis: Establishing a nerve territory concept. Maldonado AA; Spinner RJ; Broski SM; Stone JJ; Howe BM; Carter JM Acta Neurochir (Wien); 2020 May; 162(5):1137-1146. PubMed ID: 31897730 [TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid carcinoma with desmoid-type fibromatosis: A clinical, pathological, and immunohistochemical study of 14 cases. Takada N; Hirokawa M; Ito M; Ito A; Suzuki A; Higuchi M; Kuma S; Hayashi T; Kishikawa M; Horikawa S; Miyauchi A Endocr J; 2017 Oct; 64(10):1017-1023. PubMed ID: 28794344 [TBL] [Abstract][Full Text] [Related]
9. In desmoid-type fibromatosis cells sorafenib induces ferroptosis and apoptosis, which are enhanced by autophagy inhibition. Schut AW; Vriends ALM; Sacchetti A; Timbergen MJM; Alman BA; Al-Jazrawe M; Grünhagen DJ; Verhoef C; Sleijfer S; Wiemer EAC Eur J Surg Oncol; 2022 Jul; 48(7):1527-1535. PubMed ID: 35221159 [TBL] [Abstract][Full Text] [Related]
10. Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis. Sparber-Sauer M; Orbach D; Navid F; Hettmer S; Skapek S; Corradini N; Casanova M; Weiss A; Schwab M; Ferrari A Br J Cancer; 2021 May; 124(10):1637-1646. PubMed ID: 33723397 [TBL] [Abstract][Full Text] [Related]
11. Neuromuscular choristoma and circumferential nerve territory desmoid-type fibromatosis: imaging findings supporting a nerve-driven mechanism. Maldonado AA; Broski SM; Carter JM; Marek T; Howe BM; Spinner RJ J Neurosurg; 2024 Jan; 140(1):1-9. PubMed ID: 37382327 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of young patients with desmoid-type fibromatosis: Initial surveillance does not jeopardize long term quality of life. Duhil de Bénazé G; Vigan M; Corradini N; Minard-Colin V; Marie-Cardine A; Verite C; Defachelles AS; Thebaud E; Castex MP; Sirvent N; Bodet D; Mansuy L; Rome A; Petit A; Plantaz D; Jourdain A; Mary P; Carton M; Orbach D Eur J Surg Oncol; 2020 Jul; 46(7):1294-1300. PubMed ID: 32173177 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life (HRQoL), anxiety, and depression in patients with desmoid type fibromatosis. Garg V; Rastogi S; Kalra K; Bhoriwal S; Barwad A; Dhamija E; Upadhyay A; Gamangatti S Support Care Cancer; 2022 Dec; 30(12):10089-10098. PubMed ID: 36350382 [TBL] [Abstract][Full Text] [Related]
17. Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor. Skubitz KM Mayo Clin Proc; 2017 Jun; 92(6):947-964. PubMed ID: 28578783 [TBL] [Abstract][Full Text] [Related]
19. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review. McLean TD; Duchi S; Di Bella C Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study. Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]